1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,076 | 0,116 | 10:21 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.06. | Zero Candida Technologies Inc: Zero Candida granted new patent | 1 | Stockwatch | ||
| ZERO CANDIDA TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 24.06. | Zero Candida announced officially been granted Patent No. 12654025B2 -- a meaningful milestone that reflects our commitment to innovation, technology, and long-term impact | 307 | PR Newswire | VANCOUVER, BC, June 24, 2026 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a FemTech medical device company advancing next-generation... ► Artikel lesen | |
| 05.06. | Investieren in den Milliardenmarkt für Vulvovaginale Candidiasis-Therapien - Chancen und Entwicklungen | CryptoMeldungen | |||
| 25.05. | Zero Candida Technologies Inc: Zero Candida adopts semi-annual financial reporting | 2 | Stockwatch | ||
| 25.05. | Zero Candida Announces Corporate Changes | 425 | PR Newswire | VANCOUVER, BC, May 25, 2026 /PRNewswire/ -- Zero Candida (the "Company" or "ZCT"), (TSXV: ZCT) (OTC: ZCTFF) an Israeli FemTech medical device start-up, wishes to advise that it has elected... ► Artikel lesen | |
| 02.05. | Zero Candida Technologies Inc: Zero Candida CFO Galaper-Komet to resign | 1 | Stockwatch | ||
| 29.04. | Zero Candida Technologies Inc: Zero Candida director Cameron resigns | 2 | Stockwatch | ||
| 03.04. | Zero Candida Technologies Inc: Zero Candida director Kostioutchenko resigns | 1 | Stockwatch | ||
| 18.02. | Zero Candida Technologies Inc: Zero Candida scales production to 250 ZC-001 prototypes | 2 | Stockwatch | ||
| 17.02. | Zero Candida Scales Production to 250 ISO 13485 Clinical-Grade Prototypes of ZC-001 Therapeutic Device | 452 | PR Newswire | Supports GLP preclinical testing and planned Q4 2026 clinical study of at least 100 womenVANCOUVER, BC, Feb. 17, 2026 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF)... ► Artikel lesen | |
| 20.10.25 | Zero Candida Achieves Design Freeze and Begins Prototype Production of ZC-001 Therapeutic Device | 446 | PR Newswire | VANCOUVER, BC, Oct. 20, 2025 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a FemTech medical device company focused... ► Artikel lesen | |
| 03.09.25 | Zero Candida Technologies Reports Financial Results for Three and Six Months Ended June 30, 2025 and Provides Business Update | 385 | PR Newswire | VANCOUVER, BC, Sept. 3, 2025 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a Femtech company developing a SMART, AI-driven... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 69,68 | +0,01 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P MidCap 400 and Karman Holdings to Join S&P SmallCap 600 | NEW YORK, July 14, 2026 /PRNewswire/ -- S&P SmallCap 600 constituent BrightSpring Health Services Inc. (NASD: BTSG) will replace Chart Industries Inc. (NYSE: GTLS)... ► Artikel lesen | |
| BILLIONTOONE | 124,59 | -0,22 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,210 | +0,05 % | Kaplan Fox & Kilsheimer LLP: Kaplan Fox Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations | New York, New York--(Newsfile Corp. - July 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or... ► Artikel lesen | |
| BETA BIONICS | 16,860 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| GENEDX | 62,37 | -0,10 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| HEARTFLOW | 25,500 | +0,04 % | Heartflow, Inc.: New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management | ||
| ADAPTHEALTH | 10,190 | 0,00 % | AdaptHealth Flags Material Breach After Threat Actor Accessed Patient Management Systems | ||
| PROCEPT BIOROBOTICS | 19,300 | -0,05 % | PROCEPT BioRobotics to Report Second Quarter 2026 Financial Results on August 4th, 2026 | ||
| PROGYNY | 32,360 | 0,00 % | KeyBanc raises Progyny stock price target on utilization strength | ||
| LIFESTANCE HEALTH GROUP | 10,795 | +0,05 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 34,070 | -0,64 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat das Kursziel für Siemens Healthineers von 55,80 auf 54,30 Euro gesenkt, aber die Einstufung auf "Overweight" belassen. David Adlington passte seine... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 28,030 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,490 | -2,15 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 9,350 | +0,11 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Completes Acquisition of Family First Homecare and Updates Full Year 2026 Guidance | ATLANTA, June 02, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| FRESENIUS | 41,080 | +0,15 % | DAX-Rekordjagd beendet - DHL Group, Fresenius, Rheinmetall, SAP und Talanx im Check | Die Rekordjagd im DAX ist zur Wochenmitte erst einmal beendet. Gewinnmitnahmen nach dem jüngsten Hochlauf, erneute Schwäche bei KI- und Halbleiterwerten sowie schwache Vorgaben aus Asien bremsen die... ► Artikel lesen |
Das Unternehmen ZERO CANDIDA TECHNOLOGIES INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,077 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ZERO CANDIDA TECHNOLOGIES INC finden Sie auf Wallstreet Online.